NanoPainKiller
Developing a nanomaterial-based approach to treat chronic pain by selectively ablating painful sensory neurons in dorsal root ganglia (DRG) while preserving non-target neural tissue. The site describes a procedural workflow involving local delivery of nanomaterials, mapping of target DRG, and selective ablation aimed at reducing reliance on chronic systemic pain medications.
Industries
Biotechnology Research
Nr. of Employees
small (1-50)
Products
Nanomaterial-based DRG-targeted pain ablation system
A device and procedural workflow that uses locally delivered nanomaterials, DRG mapping, and targeted ablation to eliminate pain signals from specific sensory neurons while preserving most DRG tissue.
Nanomaterial-based DRG-targeted pain ablation system
A device and procedural workflow that uses locally delivered nanomaterials, DRG mapping, and targeted ablation to eliminate pain signals from specific sensory neurons while preserving most DRG tissue.
Expertise Areas
- Pain research
- Neuroscience
- Neuronal network mapping using tracers
- Nanomaterials for therapeutic intervention
Key Technologies
- Nanomaterials for selective neural ablation
- Dorsal root ganglion (DRG) targeting
- Neuronal tracer-based mapping
- Local injection delivery methods